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Abstract 
Background: There is an unresolved debate on the best screening method for hematuria as a symptom of glomeru-
lonephritis or urological malignancies. The urinary dipstick is generally considered as an imperfect surrogate for urine 
microscopy analysis.
Results: We designed a study to compare urine microscopy analysis, urinary dipstick and flow cytometry, using 
controlled dilutions of blood in urine samples from volunteers collected in two different physiologically-relevant 
conditions (basal state and hyperhydration). We found that although all techniques were 100 % effective in detecting 
hematuria at basal state, these results were variably reproduced when testing the same final amount of hematuria 
in urine collected after hyperhydration. Our data shows a variable sensitivity for the detection of hematuria by urine 
microscopy analysis or flow cytometry, but not by urinary dipstick.
Conclusions: Urinary dipstick qualifies as a better screening test for hematuria than urine microscopy analysis or flow 
cytometry, as it is sensitive and performs better in unstandardized conditions. It is universally available and also faster 
and cheaper than cytometric techniques.
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Findings
Background
Screening for hematuria is recommended in many situ-
ations, including screening of high risk patients in occu-
pational medicine [1–3] and tests are expected to be 
sensitive. Missed or delayed diagnosis of hematuria may 
lead to neglecting urological (cancer) or nephrological 
(glomerulonephritis) life-threatening diseases [4]. There 
has long been a debate as to whether urine dipstick or 
urine microscopy analysis (UMA) is the preferred testing 
method, but there is no consensus amongst practition-
ers [5, 6]. UMA performance may be altered by red blood 
cell (RBC) degradation in urine, and urine dipstick may 
misdiagnose hemoglobinuria or myoglobinuria as hema-
turia [6]. To our knowledge, no controlled study has com-
pared urine dipstick and UMA to an independent gold 
standard, and studies evaluating the urine dipstick using 
UMA as a benchmark do not evaluate the diagnostic per-
formance of UMA itself. Our objective was to compare 
urine dipstick and UMA as a diagnostic test for hematu-
ria, using urine samples with a known concentration of 
RBC.
Methods
We obtained a calibration by diluting a controlled 
amount of blood in urine. Control urine was collected 
from volunteers (healthy young males to avoid genital 
blood contamination) after informed oral consent. 50 mL 
midstream urine was collected at baseline and after 1.5 L 
of water ingestion. Blood was taken from one volunteer, 
diluted in urine to 1:103, and ten fold serial dilutions in 
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urine were performed up to 1:108. Urine dipstick (Multi-
stix® 8SG, Siemens) with an automatic analyser (Clinitek 
Status®) yielded semi-quantitative results (0, prints, +, 
++, +++, Additional file  1). Urine microscopic analy-
sis at a 400-fold optical magnification (Leitz Wetzlar® 
Ortholux) in 1  µL counting chambers allowing quanti-
tative per volume assessment of hematuria [7] and flow 
cytometry (MACSQuant® Analyser, Miltenyi Biotec) 
gating RBC on a side scatter versus forward scatter plot 
yielded a count/mm3 (Additional files 2 and 3 respec-
tively). Data are summarized as median and interquartile 
range. Two-sided Wilcoxon tests were performed at 0.05 
significance level, and paired when appropriate using R 
statistical package (version 2.14.1).
Using serial dilutions, we found that urine dipstick, 
UMA and flow cytometry detected hematuria at the 
threshold of 1:106 blood dilution, with the greatest sen-
sitivity for flow cytometry (100  %), followed by urine 
dipstick (83 %) and UMA (64 %). At the 1:105 dilution, 
all three techniques had 100  % sensitivity (Fig.  1), and 
we thus decided to use this dilution to compare the 
robustness of the three different test depending on 
hydration.
Results
We collected urine after water ingestion to evalu-
ate the three methods in a different clinical setting and 
to compare to baseline control urine. As expected, we 
found that urine density decreased after water load 
[1010 (1006; 1010) vs. 1030 (1022; 1030), p  =  0.034]. 
When we assessed the three different methods in base-
line and hypotonic urine, using the same 1:105 dilu-
tion, we found that the cytomorphological tests (UMA 
and flow cytometry) were not reproducible, with a 
systematic underestimation of hematuria (57  % median 
fold decrease, p = 0.036 and 92 % median fold decrease, 
p = 0.031, respectively) whereas assessment by the urine 
dipstick conserved its sensitivity (++ positivity) (Fig. 2).
We compared the sensitivity of three different meth-
ods for diagnosing hematuria, and the robustness of 
these methods when there is a clinically relevant change 
in urine composition. Urine dipstick was more sensitive 
than UMA, especially in hypotonic urine. The enhanced 
sensitivity of the dipstick is explained by its ability to 
detect heme even after RBC lysis. We performed the 
blood dilutions with urine collected at basal state and 
after hydration to ensure that the chemical and physical 
conditions were relevant to patients with hematuria. This 
is very relevant to urological hematuria (i.e. a bleeding 
occurring directly in urine), and perhaps less to nephro-
logical hematuria (where the RBC journey with primary 
urine in the tubules). We chose to evaluate the detection 
of hematuria independently of the effect of changes in 
diuresis, but this parameter could enhance the effect of 
hydration that we observed: in patients, hypotonic urine 
is often associated with increased diuresis and urine dilu-
tion could further decrease the sensitivity of hematuria 
detection. The dipstick can be performed immediately, 
but UMA needs to be brought to the laboratory first, and 
delay also reduces the sensitivity of UMA [8].
Conclusions
Thus, instead of considering the urine dipstick as a sur-
rogate marker for UMA, it should be the preferred 
method for screening hematuria. Timed urine samples 
were once considered to be the gold standard, but UMA 
is now recommended by most guidelines. We believe that 
UMA may not be reliable if performed in unstandardized 
Fig. 1 Detection of hematuria by urine dipstick, UMA or flow cytom-
etry at increasing concentrations of RBC
Fig. 2 Results of UMA, urine dipstick and flow cytometry for hematu-
ria in baseline and hypotonic urine
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conditions, and that it should rather be a confirmatory 
test performed in controlled conditions (midstream urine 
harvested in the morning when it is more acid and hyper-
tonic), to rule out isolated pigmenturia and to detect dys-
morphic RBC. The urine dipstick should, therefore, be 
preferred for the screening of hematuria as it is more sen-
sitive and cheaper than UMA.
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